NWPF

News ArchivesRead News

Your Parkinson's News Update for the Week of 7/20/20

Monday July 20, 2020
The Link Between Parkinson’s and Toxic Chemicals
The New York Times
"Ending Parkinson's Disease" authors call the increasing prominence of Parkinson’s 'a man-made pandemic.' "Its prevalence has closely tracked the growth of industrialization and has increased dramatically with the use of pesticides, industrial solvents and degreasing agents in countries throughout the world.
'Over the last 25 years,' the authors noted, 'the prevalence rates for Parkinson’s, adjusted for age, increased by 22 percent for the world, by 30 percent for India, and by 116 percent for China.”
Furthermore, they added, men, who are more likely to work in occupations that expose them to industrial products linked to the disease, have a 40 percent greater risk than women of developing it."
World Brain Day 2020 "Moves to End Parkinson's"
World Federation of Parkinson's via Yahoo
Through this initiative, the World Federation of Neurology is working alongside more than 122 global organizations to advocate for improved patient care, education, and additional research for those living with Parkinson's and their caregivers.
To elevate Parkinson's awareness, WFN is hosting a free webinar on July 22 at 12:30pm Coordinated Universal Time (UTC) with some of the world's leading neurologists, patient advocates and Parkinson's Disease experts to offer vital insights on the disease, as well as discuss the current state of prevention, diagnosis and treatment. To register to attend, visit www.wfneurology.org.
Parkinson's Foundation Announces Results of
PD GENEration Pilot Study
PR Newswire
"Previous studies have shown that neither patients with Parkinson's nor Parkinson's specialists are confident that medications are administered on time in the hospital setting, and up to 30% of carbidopa-levodopa doses are not given within an hour of the scheduled time," explained lead investigator Martha A. Nance, MD, Park Nicollet Struthers Parkinson's Center, Golden Valley, MN, USA, where the project took place.
"Through a collaborative effort at our hospital that included contributions from Parkinson's specialists, hospitalist physicians, pharmacists, nurses, nursing administration, and information technology--and most importantly, patients and families--we were able to introduce strategies to substantially improve the timely administration of doses."